4//SEC Filing
Murugan Amar 4
Accession 0001140361-22-042379
CIK 0001604464other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 8:13 PM ET
Size
12.4 KB
Accession
0001140361-22-042379
Insider Transaction Report
Form 4
Murugan Amar
SVP, GC & Secretary
Transactions
- Sale
Common Stock
2022-11-16$4.49/sh−3,612$16,218→ 127,586 total
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 16, 2022 and November 17, 2022 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001809916
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 8:13 PM ET
- Size
- 12.4 KB